Table 6.
Eradication group (No of events) | Eradication costs ($C) | Placebo group (No of events) | Placebo costs ($C) | |
---|---|---|---|---|
Admissions to hospital for stomach problems | 1 | 432 | 6 | 2 592 |
Visits to family practitioner | 120 | 2 186 | 150 | 2 787 |
Visits to specialist (surgeon or gastroenterologist) | 24 | 1 631 | 32 | 2 033 |
Upper gastrointestinal barium study | 13 | 1 103 | 14 | 1 188 |
Upper gastrointestinal endoscopy | 11 | 1 041 | 16 | 1 514 |
Cost of prescription drugs for dyspepsia* | 179 prescriptions (73 patients) | 25 816 | 299 prescriptions (87 patients) | 38 974 |
Cost of non-prescription drugs for dyspepsia† | – | 3 527 | – | 4 486 |
Laboratory tests | 24 | 714 | 36 | 1 254 |
Days of work missed | 263 (30 patients) | 16 910 | 226 (24 patients) | 13 200 |
Other‡ | 53 | 2 138 | 61 | 2 663 |
1 $C≈0.60 US$≈£0.43.
Costs include drug treatment at start of study; costs taken from a log of gastrointestinal medications; includes antibiotics given for repeat Helicobacter pylori eradication treatment during the study.
Cost of non-prescription drugs paid by the patient as reported in the questionnaire; the number and types of drugs taken were not captured.
Includes visits to a nurse, imaging studies (abdominal and chest radiography, ultrasonography of abdomen and pelvis, computed tomography of abdomen, barium enema), sigmoidoscopy, one colonoscopy, and transportation costs.